Researchers have announced that, for patients with acute lymphoblastic leukaemia (ALL) driven by the Philadelphia chromosome, the drug dasatinib provides more benefit than the standard-of-care drug imatinib.
US and Chinese resear...
4 months ago
The survival rate for bone marrow transplant recipients has risen, thanks to a decrease in complications, new analysis has found.
Writing in the latest edition of the Annals of Internal Medicine, the researchers say that the over...
4 months ago